Trading Options with an Edge
Select Page

CLDX

Search by
TICKER SYMBOL

Celldex Therapeutics Inc.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

33.18

-0.46

(-1.367%)

Volume:

79,152

52 week range:

19.85 - 42.46

Market Cap:

1.563B

Company Description:

Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.